IMS trades up after allocation
A Eu550m term loan from US pharmaceutical industry intelligence provider IMS Health traded up in the secondary market after being allocated to lenders on Wednesday, said market participants.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast
